Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

EVP, Gen. Counsel & Secretary

Chief Accounting Officer

Chief Financial Officer

CEO and President

Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and int...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-15	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Gen. Counsel & Secretary
2024-04-01	Premium	sold	Premium	Premium	Premium	EVP, Gen. Counsel & Secretary
2024-04-01	Premium	sold	Premium	Premium	Premium	-
2024-03-15	Premium	acquired	Premium	Premium	Premium	EVP, Gen. Counsel & Secretary
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Gen. Counsel & Secretary
2024-03-15	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-03-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-06	Premium	acquired	Premium	Premium	Premium	CEO and President
2024-03-04	Premium	sold	Premium	Premium	Premium	-
2024-03-01	Premium	sold	Premium	Premium	Premium	EVP, Gen. Counsel & Secretary
2024-03-01	Premium	sold	Premium	Premium	Premium	-
2024-02-16	Premium	acquired	Premium	Premium	Premium	-
2024-02-16	Premium	acquired	Premium	Premium	Premium	-
2024-02-16	Premium	acquired	Premium	Premium	Premium	-
2024-02-16	Premium	acquired	Premium	Premium	Premium	-
2024-02-16	Premium	acquired	Premium	Premium	Premium	-
2024-02-16	Premium	acquired	Premium	Premium	Premium	-
2024-02-16	Premium	acquired	Premium	Premium	Premium	-
2024-01-03	Premium	sold	Premium	Premium	Premium	-
2024-01-02	Premium	sold	Premium	Premium	Premium	-
2023-12-27	Premium	acquired	Premium	Premium	Premium	EVP, Gen. Counsel & Secretary
2023-12-16	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-12-15	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Gen. Counsel & Secretary

PEN - Penumbra Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for PEN